Survivin-derived peptide epitopes and their role for induction of antitumor immunity in hematological malignancies - Wikidata - awgldk - TriplyDB

Survivin-derived peptide epitopes and their role for induction of antitumor immunity in hematological malignancies

Survivin-derived peptide epitopes and their role for induction of antitumor immunity in hematological malignancies

http://www.wikidata.org/entity/Q28251858

about

Targeting survivin in cancer Cross-validation of survival associated biomarkers in gastric cancer using transcriptomic data of 1,065 patients Survivin, a molecular target for therapeutic interventions in squamous cell carcinoma.NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantatio Association of survivin splice variants with prognosis and treatment of breast cancer.Strategies for the identification of T cell-recognized tumor antigens in hematological malignancies for improved graft-versus-tumor responses after allogeneic blood and marrow transplantation Prostate Cancer Immunotherapy: Exploiting the HLA Class II Pathway in Vaccine Design Dendritic cell vaccines targeting survivin in head and neck cancer.

P2860

Q27012954-D4845FBB-DB07-4BCA-B7BE-1CE6E8752809 Q31112933-CD2E80A4-7B13-4D0D-9527-33116022F86F Q33634679-DE361C2A-70DB-4772-94B9-5DC9370A66C2 Q34202277-F1AA92B2-3F1A-49A6-8E13-4F1FB22C9D64 Q34657717-248FF47A-F255-454A-9969-913F1B2EDAF7 Q35588845-2193400C-BA5B-41A9-A2F1-B1523041D2BC Q36487242-28F0F8B4-EA88-4050-9A66-F9F09EB7AE55 Q44567444-8A035D5A-D7B7-4F82-AAB0-73BCEFB3DFEA

P2860

Survivin-derived peptide epitopes and their role for induction of antitumor immunity in hematological malignancies

http://www.wikidata.org/entity/Q28251858

description

2006 nî lūn-bûn

@nan

2006 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Survivin-derived peptide epito ...... in hematological malignancies

@ast

Survivin-derived peptide epito ...... in hematological malignancies

@en

Survivin-derived peptide epito ...... in hematological malignancies

@nl

type

label

Survivin-derived peptide epito ...... in hematological malignancies

@ast

Survivin-derived peptide epito ...... in hematological malignancies

@en

Survivin-derived peptide epito ...... in hematological malignancies

@nl

prefLabel

Survivin-derived peptide epito ...... in hematological malignancies

@ast

Survivin-derived peptide epito ...... in hematological malignancies

@en

Survivin-derived peptide epito ...... in hematological malignancies

@nl

P1433

Q28251858-D3106A62-07E9-470C-8AC8-FDFC21998B68

P1476

Q28251858-72DA0486-67EF-4B21-9097-98FF9D5A00E8

P2093

Q28251858-414318DB-14FE-4018-8ACB-BCD61BCAEF4F

Q28251858-44F5AB5B-2AC7-440B-AF16-7ACE0D9A4D26

Q28251858-8FFF0607-5A02-4F38-8A8F-B7F82B640C17

Q28251858-D0F76E9E-B0F0-4EDD-B60B-E9E9B267CAFA

Q28251858-DA56092B-E998-4BFB-89BF-7BC5721D1143

P2860

Q28251858-02E944B0-5D92-4280-838C-BA7F73EDC0F3

Q28251858-05661B03-757E-4A10-A2A0-B112E5ECF806

Q28251858-135C41D5-2701-44BF-8719-C00D3D5B7ED1

Q28251858-17A488E4-B4B2-4DC7-A372-B6CB811D835E

Q28251858-1C3C22B8-867F-4809-AFAE-F94B15C537FB

Q28251858-1D6FD985-92F6-494F-8CBD-2614D578481C

Q28251858-214D3DD3-83BD-41E6-AEF4-F329538D84CA

Q28251858-278DCBC3-D6DD-4A62-8196-82532ACEC1CC

Q28251858-2B0CB4E2-1308-447A-B6B4-39B8C74308C4

Q28251858-320B4338-A56D-41B1-9CDE-C30122A1A3F8

P304

Q28251858-ADD801DA-CA55-4B8C-87D2-2506D2231E29

P31

Q28251858-13E8A982-17A3-45AE-A8C9-EC7DC6B51A82

P3181

Q28251858-D022547F-55D0-4B03-8FC8-9FD682B32140

P356

Q28251858-CB1AF091-E1A9-46E2-9317-80824C54B2F7

P407

Q28251858-3456B0C6-14CE-4195-A820-D76B1EB07044

P433

Q28251858-1B88EDD9-6847-4E92-A5FE-41C652F8218E

P478

Q28251858-90162050-45CB-4704-B0F3-05A5D853214B

P577

Q28251858-2FFA0B02-E72D-4D4F-9BD6-CF594F47D4FD

P698

Q28251858-A3B1DFCB-4E24-4DD5-B87E-7B8B894721F8

P3181

P356

10428190500464062

P1433

Leukemia & Lymphoma

P1476

Survivin-derived peptide epito ...... in hematological malignancies

@en

P2093

Birte Friedrichs

http://www.w3.org/2001/XMLSchema#string

Mads Hald Andersen

http://www.w3.org/2001/XMLSchema#string

Matthias Zeis

http://www.w3.org/2001/XMLSchema#string

Norbert Schmitz

http://www.w3.org/2001/XMLSchema#string

Sandra Siegel

http://www.w3.org/2001/XMLSchema#string

P2860

A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma

Phase I clinical study of anti-apoptosis protein, survivin-derived peptide vaccine therapy for patients with advanced or recurrent colorectal cancer

Survivin 2alpha: a novel Survivin splice variant expressed in human malignancies

Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition

Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins

Validating survivin as a cancer therapeutic target

Apoptosis in the pathogenesis and treatment of disease

Induction of apoptosis and inhibition of cell proliferation by survivin gene targeting

SYFPEITHI: database for MHC ligands and peptide motifs

NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation

P304

978-85

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4712664

http://www.w3.org/2001/XMLSchema#string

P356

10.1080/10428190500464062

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

47

http://www.w3.org/2001/XMLSchema#string

P577

2006-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16840186

http://www.w3.org/2001/XMLSchema#string